NCT06893653

Brief Summary

Although tDCS and FV have shown some benefit as stand-alone treatment, researcher suggest that combining intervention with complementary mechanism can lead to additive or synergistic benefits which might yield more significant improvement in functional outcome hence the author propose to plan the combination of FV with tDCS for motor recovery /spasticity in stroke patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 25, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

April 16, 2025

Status Verified

April 1, 2025

Enrollment Period

9 months

First QC Date

March 19, 2025

Last Update Submit

April 15, 2025

Conditions

Keywords

stroketDCSmotor activityspasticity

Outcome Measures

Primary Outcomes (2)

  • Fugl Meyr Assessment

    FMA is used for the assessment of physical performance and sensorimotor function of neurological patients. It uses a 3-point ordinal scale to score individuals' ability to perform a certain task. Total score is 226. It has excellent inter and intrarater reliability

    20th week

  • Modified Ashworth Scale

    MAS is a tool to measure hypertonia. It scores the resistance on a 5 point ordinal scale with an increase value indicating hypertonia. Intrarater reliability of MAS was found to be good to excellent for upper (k= 0.71-0.94) and lower extremities(k= 0.55-0.97) while interrater reliability was poor to moderate for upper (k= 0.25-0.66) and lower extremities

    20th week

Secondary Outcomes (1)

  • Stroke Specific Quality of Life questionnaire

    20th week

Study Arms (4)

FMV

ACTIVE COMPARATOR

FMV + PT

Device: Focal muscle vibrationOther: Physical Therapy

tDCS

ACTIVE COMPARATOR

tDCS + PT

Device: tDCSOther: Physical Therapy

FMV & tDCS

ACTIVE COMPARATOR

FMV + tDCS + PT

Other: Physical TherapyDevice: Focal muscle vibration & tDCS

PT

ACTIVE COMPARATOR

PT only

Other: Physical Therapy

Interventions

FMV will be applied to the muscle belly along with the conventional physical therapy

FMV
tDCSDEVICE

tDCS will be applied to M1 area of brain along with the conventional physical therapy

tDCS

Conventional physical therapy will be provided

FMVFMV & tDCSPTtDCS

Focal muscle vibration with tDCS and conventional physical therapy will be provided.

FMV & tDCS

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Chronic stroke
  • Spasticity \> 1 at Modified Ashworth Scale.
  • FMA score more than 36

You may not qualify if:

  • Metallic implant including shunt, intracranial pacemaker, surgical clip etc.
  • Any neurological disorder other than stroke
  • Any Orthopedic impairment that limit the motor recovery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pakistan Railway Hospital

Rawalpindi, Punjab Province, Pakistan

RECRUITING

Related Publications (3)

  • Chow AD, Shin J, Wang H, Kellawan JM, Pereira HM. Influence of Transcranial Direct Current Stimulation Dosage and Associated Therapy on Motor Recovery Post-stroke: A Systematic Review and Meta-Analysis. Front Aging Neurosci. 2022 Mar 18;14:821915. doi: 10.3389/fnagi.2022.821915. eCollection 2022.

    PMID: 35370603BACKGROUND
  • Wang H, Yu H, Liu M, Xu G, Guo L, Wang C, Sun C. Effects of tDCS on brain functional network of patients after stroke. IEEE Access. 2020 Nov 13;8:205625-34

    BACKGROUND
  • Wang H, Chandrashekhar R, Rippetoe J, Ghazi M. Focal muscle vibration for stroke rehabilitation: a review of vibration parameters and protocols. Applied Sciences. 2020 Nov 21;10(22):8270

    BACKGROUND

MeSH Terms

Conditions

StrokeMotor ActivityMuscle Spasticity

Interventions

Transcranial Direct Current StimulationPhysical Therapy Modalities

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBehaviorMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological TechniquesRehabilitation

Study Officials

  • Mirza Obaid Baig, MSPT

    Riphah International University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mirza Obaid Baig, MSPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2025

First Posted

March 25, 2025

Study Start

April 1, 2025

Primary Completion

December 31, 2025

Study Completion

January 31, 2026

Last Updated

April 16, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations